Menu Search
Equities

Guardian Pharmacy Services, Inc.

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GRDN:NYQ

Guardian Pharmacy Services, Inc.

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)39.47
  • Today's Change-0.21 / -0.53%
  • Shares traded426.03k
  • 1 Year change+61.96%
  • Beta--
Data delayed at least 15 minutes, as of Oct 16 2026 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Guardian Pharmacy Services, Inc. grew revenues 17.93% from 1.23bn to 1.45bn while net income improved from a loss of 87.29m to a gain of 49.22m.
Gross margin21.63%
Net profit margin4.55%
Operating margin5.84%
Return on assets16.63%
Return on equity31.75%
Return on investment27.73%
More ▼

Cash flow in USDView more

In 2025, Guardian Pharmacy Services, Inc. increased its cash reserves by 1,308.13%, or 60.96m. The company earned 100.26m from its operations for a Cash Flow Margin of 6.92%. In addition the company used 32.23m on investing activities and also paid 7.07m in financing cash flows.
Cash flow per share1.40
Price/Cash flow per share27.96
Book value per share3.88
Tangible book value per share2.36
More ▼

Balance sheet in USDView more

Guardian Pharmacy Services, Inc. uses little or no debt in its capital structure.
Current ratio1.65
Quick ratio1.33
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 143.81%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
EPS growth(5 years)19.34
EPS (TTM) vs
TTM 1 year ago		167.35
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.